Vincent Jongkind,Max Hoebink/LinkedIn
Mar 30, 2026, 17:35
Vincent Jongkind: Everything You Need to Know on The Use of Anti-Xa During Arterial Procedures
Vincent Jongkind, Vascular Surgeon at Amsterdam UMC and Treasurer of European Society for Vascular Surgery, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Max Hoebink and team have written a systematic review on the use of anti-Xa during arterial procedures in Journal of Thrombosis and Haemostasis (JTH).
Everything you need to know.”
Title: Clinical applicability of anti-Xa measurements to monitor unfractionated heparin activity during arterial procedures: a scoping review
Authors: Max Hoebink, Thomas Steunenberg, Sjoerd Smit, Henrike Hamer, Arno Wiersema, Kak Khee Yeung, Vincent Jongkind
Read the Full Article on JTH
Stay updated on all scientific advances with Hemostasis Today.
-
May 22, 2026, 12:29Neema Ngugi: Highlighting 6 Major Types of Anemia
-
May 22, 2026, 12:27Jacinto López Sagaseta: Solving the Structural Puzzle of FVIIa–EPCR Interaction
-
May 22, 2026, 12:25Shehab Mohamed: Exploring the Emerging Link Between JAK2 Mutations and Thoracic Aortic Aneurysms
-
May 22, 2026, 11:52Prakash W. Kamat: Highlighting the Role of Physical Activity in Hemophilia Management
-
May 22, 2026, 11:43Mohamed Hanafy Morsy: Understanding Hemochromatosis – Genetics Made Simple
-
May 22, 2026, 10:23Rucha Patil: Insights from The National Haemophilia Conclave 2026
-
May 22, 2026, 10:11Narat Srivali: New Systematic Review and Meta-Analysis on Glucocorticoid Therapy and The Risk of VTE
-
May 22, 2026, 10:02Greta Mulders: Nursing Leadership in Haemophilia Gene Therapy
-
May 22, 2026, 08:45Dirk Sibbing: Ethnicity and Antiplatelet Therapy Outcomes in CCS